NAVI
55
-3
DE
59
-3
GOOGL
56
3
SYK
40
-6
CB
51
-2
VIX
43
2
BXP
62
2
AAP
50
2
AA
70
-2
HSY
34
2
CPB
30
3
AN
60
-12
UA
24
-5
MLM
58
-2
WY
59
3
FOXA
59
-4
CAT
72
10
ADSK
53
9
FOX
60
-8
HD
38
-3
NAVI
55
-3
DE
59
-3
GOOGL
56
3
SYK
40
-6
CB
51
-2
VIX
43
2
BXP
62
2
AAP
50
2
AA
70
-2
HSY
34
2
CPB
30
3
AN
60
-12
UA
24
-5
MLM
58
-2
WY
59
3
FOXA
59
-4
CAT
72
10
ADSK
53
9
FOX
60
-8
HD
38
-3
Financhill
Back

Sarepta Therapeutics Stock Predictions

7 Stocks to Consider Immediately (must-see chart)

See the green days for 7 major stocks right here, free of charge
Sell
43

SRPT
Sarepta Therapeutics

Last Price:
$18.17
Seasonality Move:
37.39%

7 Day Trial

ALL ACCESS PASS

$ 7

This Tech Company Grew 32,481%...

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.

Sarepta Therapeutics Stock Forecast

  • Over the next 52 weeks, Sarepta Therapeutics has on average historically risen by 46.1% based on the past 28 years of stock performance.
  • Sarepta Therapeutics has risen higher in 16 of those 28 years over the subsequent 52-week period, corresponding to a historical accuracy of 57.14%
  • Is Sarepta Therapeutics Stock Undervalued?
    The current Sarepta Therapeutics [SRPT] share price is $18.17. The Score for SRPT is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
  • SRPT is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.

Will Sarepta Therapeutics Stock Go Up Next Year?

  • Over the next 52 weeks, Sarepta Therapeutics has on average historically risen by 46.1% based on the past 28 years of stock performance.

Sarepta Therapeutics Stock Rating

Sell
43
Sarepta Therapeutics (SRPT) is a Sell

Is Sarepta Therapeutics overpriced?

  • Sarepta Therapeutics has risen higher in 16 of those 28 years over the subsequent 52-week period, corresponding to a historical accuracy of 57.14%

Sarepta Therapeutics Stock Price History

Is SRPT stock going to rise?

  • Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SRPT is experiencing selling pressure, which indicates risk of future bearish movement.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
sarepta.com

52-Week Data

52-Week High:
154.13
52-Week Low:
16.88

Prediction Charts

Market Cap:
1.8B
Price in USD:
18.17
Volume:
3.1M
Beta:
1.01

Technical Analysis

SMA50:
33.21
SMA100:
56.08
SMA200:
88.75
52-Wk Change:
-88.05%

Stock Predictions

  • Is Sarepta Therapeutics stock public?
    Yes, Sarepta Therapeutics is a publicly traded company.
  • What is the Sarepta Therapeutics stock quote today?
    The Sarepta Therapeutics stock price is 18.17 USD today.
  • How to buy Sarepta Therapeutics stock online?
    You can buy Sarepta Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Jun-23 19.76 18.87 19.76 18.70
Jun-24 19.14 18.98 19.43 18.68
Jun-25 18.88 17.46 18.88 17.00
Jun-26 17.66 17.23 17.79 16.99
Jun-27 17.30 17.11 17.69 16.97
Jun-30 17.24 17.10 17.52 16.96
Jul-1 17.15 17.71 18.62 16.88
Jul-2 17.70 18.20 18.35 17.63
Jul-3 18.45 18.24 18.64 18.02
Jul-7 18.03 17.32 18.27 17.31
Jul-8 17.49 19.03 19.36 17.35
Jul-9 18.98 19.37 19.74 18.90
Jul-10 19.43 19.07 19.53 18.50
Jul-11 18.96 18.17 18.96 17.95

Sarepta Therapeutics Earnings

Sarepta Therapeutics Earnings Report: Per Share Sarepta Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.

Sarepta Therapeutics Forecast Revenue Growth

Sarepta Therapeutics Stock Analysis: Historical quarterly revenues per share for Sarepta Therapeutics and historical quarterly revenue growth:

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, an increase next quarter of $0.75 per share, a decrease this year of $5.87 per share, and an increase next year of $5.35 per share.

* Sarepta Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.